Screening for antibodies in narcolepsy type 1 and type 2

Screening for antibodies in narcolepsy type 1 and type 2

Dettagli Bibliografici
Autori principali:	Giannoccaro, M, Waters, P, Pizza, F, Liguori, R, Plazzi, G, Vincent, A
Natura:	Conference item
Pubblicazione:	Wiley 2017

Documenti analoghi

Antibodies against hypocretin receptor 2 are rare in narcolepsy
di: Giannoccaro, M, et al.
Pubblicazione: (2016)

Human hypocretin receptor 2 antibodies are rare in idiopathic narcolepsy
di: Giannoccaro, M, et al.
Pubblicazione: (2016)

Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder
di: Giannoccaro MP, et al.
Pubblicazione: (2021-05-01)

Pediatric Narcolepsy Type 1: A State-of-the-Art Review
di: Valentina Baldini, et al.
Pubblicazione: (2024-06-01)

Creativity in Narcolepsy Type 1: The Role of Dissociated REM Sleep Manifestations
di: D'Anselmo A, et al.
Pubblicazione: (2020-12-01)

Dream Generation and Recall in Daytime NREM Sleep of Patients With Narcolepsy Type 1
di: Carlo Cipolli, et al.
Pubblicazione: (2020-11-01)

Physical Activity and Sleep/Wake Behavior, Anthropometric, and Metabolic Profile in Pediatric Narcolepsy Type 1
di: Marco Filardi, et al.
Pubblicazione: (2018-08-01)

Hypothalamus and amygdala functional connectivity at rest in narcolepsy type 1
di: Daniela Ballotta, et al.
Pubblicazione: (2021-01-01)

Case Report: Burden of Illness in Narcolepsy Type 1: Hikikomori in a Teenage Girl
di: Marco Filardi, et al.
Pubblicazione: (2021-03-01)

Navigating narcolepsy: exploring coping strategies and their association with quality of life in patients with narcolepsy type 1
di: Giorgia Varallo, et al.
Pubblicazione: (2024-05-01)

Validation of the Russian version of Swiss Narcolepsy Scale for narcolepsy type 1 screening
di: A. O. Golovatyuk, et al.
Pubblicazione: (2024-08-01)

Auxological and endocrine findings in narcolepsy type 1: seventeen-year follow-up from a pediatric endocrinology center
di: Sara Casale, et al.
Pubblicazione: (2023-06-01)

Impact of COVID‐19 pandemic lockdown on narcolepsy type 1 management
di: Emanuela Postiglione, et al.
Pubblicazione: (2021-01-01)

Autism Spectrum Disorder and Narcolepsy: A Possible Connection That Deserves to Be Investigated
di: Annio Posar, et al.
Pubblicazione: (2020-04-01)

Narcolepsy type 1
di: Rajesh Swarnakar, et al.
Pubblicazione: (2019-01-01)

Grey zone between narcolepsy type 1 and type 2
di: Gustavo Bruniera Fernandes, et al.

Gut Microbiota in Patients with Type 1 Narcolepsy
di: Zhang R, et al.
Pubblicazione: (2021-11-01)

Neuronal antibodies in children with or without narcolepsy following H1N1-AS03 vaccination
di: Thebault, S, et al.
Pubblicazione: (2015)

Comparing symptom measurement tools in pediatric narcolepsy
di: Philippe Lehert, et al.
Pubblicazione: (2022-12-01)

Progress of autonomic disturbances in narcolepsy type 1
di: Ying Wang, et al.
Pubblicazione: (2023-03-01)

Serum N‑Glycan Profiling of Patients with Narcolepsy Type 1 Using LC-MS/MS
di: Akeem Sanni, et al.
Pubblicazione: (2024-07-01)

Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases.
di: Guo Luo, et al.
Pubblicazione: (2017-01-01)

Orgasmolepsy in Narcolepsy Type 1 Responsive to Pitolisant: A Case Report
di: Pellitteri G, et al.
Pubblicazione: (2020-12-01)

Rare Case of Late-Onset Narcolepsy Type 1
di: Petra Kovalská, et al.
Pubblicazione: (2020-11-01)

Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: TElemedicine for NARcolepsy (TENAR)
di: Francesca Ingravallo, et al.
Pubblicazione: (2020-05-01)

Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination.
di: Simon Thebault, et al.
Pubblicazione: (2015-01-01)

Can a Peer Support the Process of Self-Management in Narcolepsy? A Qualitative Narrative Analysis of a Narcoleptic Patient
di: Christian Franceschini, et al.
Pubblicazione: (2020-07-01)

Correction: Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases.
di: Guo Luo, et al.
Pubblicazione: (2019-01-01)

Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
di: Vellieux G, et al.
Pubblicazione: (2021-09-01)

Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling
di: Helle Sadam, et al.
Pubblicazione: (2018-03-01)

Rarely Observed Symptoms in Narcolepsy Type-1 Case: Hypersexuality
di: Remzi Emre Şahin, et al.
Pubblicazione: (2024-09-01)

Quickly diagnosed and treated prepubertal Type 1 narcolepsy case
di: Fikret Poyraz Çökmüş, et al.
Pubblicazione: (2018-04-01)

Narcolepsy Type 1: Should We Only Target Hypocretin Receptor 2?
di: Rolf Fronczek, et al.
Pubblicazione: (2023-09-01)

LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1
di: Akeem Sanni, et al.
Pubblicazione: (2023-02-01)

Role of Brown Adipose Tissue in Adiposity Associated With Narcolepsy Type 1
di: Maaike E. Straat, et al.
Pubblicazione: (2020-04-01)

Is narcolepsy an antibody-mediated autoimmune disease
di: Thebault, S
Pubblicazione: (2012)

Muscle Pain Sensitivity and Prevalence of Temporomandibular Disorders in Patients with Narcolepsy with Cataplexy: A Controlled Cohort Study
di: Maria Lavinia Bartolucci, et al.
Pubblicazione: (2023-06-01)

Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening
di: Thi-Tuyet Trinh Tran, et al.
Pubblicazione: (2024-01-01)

Type 1 Narcolepsy in Pregnancy: A Case Report and Review of Literature
di: Asnat Yuabov, et al.
Pubblicazione: (2024-04-01)

A study on the optimal length of actigraphic recording in narcolepsy type 1
di: Damien Leger, et al.
Pubblicazione: (2019-01-01)